The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Rose Foster
No Relationships to Disclose
 
Adrian Larkeryd
No Relationships to Disclose
 
Luis Zapata
No Relationships to Disclose
 
Joao Galante
No Relationships to Disclose
 
Tatiany Silveria
Employment - Royal Marsden Hospital NHS Foundation Trust
 
Hannah Crook
No Relationships to Disclose
 
Floriana Monodoro
No Relationships to Disclose
 
Shichina Kannambath
No Relationships to Disclose
 
Laura Satchwell
No Relationships to Disclose
 
Simon Connolly
No Relationships to Disclose
 
Ana Hughes
No Relationships to Disclose
 
Anne-Marie Hodgkins
Research Funding - AstraZeneca
 
Thomas Lund
No Relationships to Disclose
 
Manuel Salto-Tellez
No Relationships to Disclose
 
Shaista Hafeez
Employment - Royal Marsden NHS Foundation Trust
 
Robert Huddart
Leadership - Cancer Clinic London Limited Liability Partnership
Consulting or Advisory Role - Bayer; BioNTech; Gilead Sciences; Janssen Oncology; Merck; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - Bristol Myers Squibb Foundation; Pfizer
Research Funding - Astellas Pharma (Inst); Basilea (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen
Travel, Accommodations, Expenses - Janssen; Nektar; Roche/Genentech
 
Anguraj Sadanandam
Consulting or Advisory Role - Ploughshare Innovations
Research Funding - Bristol-Myers Squibb; Merck KGaA; Pierre Fabre
Patents, Royalties, Other Intellectual Property - “Molecular predictors of therapeutic response to specific anti-cancer agents” (patent number US9506926B2); Patent - ‘Colorectal cancer classification with differential prognosis and personalized therapeutic responses’ (patent number PCT/IB2013/060416); Patient classification and prognostic method (GEP-NET) – Priority Patent - EP18425009.0; Prognostic and treatment response prediction in gastric cancer – Priority Patent CSC/BP7295892
 
Alan Melcher
No Relationships to Disclose
 
Nicholas James
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Janssen Oncology; Merck; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi
 
Anna Wilkins
Speakers' Bureau - Johnson & Johnson
Research Funding - Artera AI; AstraZeneca; Roche/Genentech; Veracyte